Description

Allyl 3,9-Diazaspiro[5.5]Undecane-3-Carboxylate Hydrochloride (Wxc00471) is a high-purity, advanced pharmaceutical intermediate featuring a complex spirocyclic diamine structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated molecular scaffolds. Research and development teams in the pharmaceutical and biotechnology sectors utilize this intermediate to accelerate the discovery and development of new drug candidates, leveraging its unique chemical framework to impart specific biological activity and pharmacokinetic properties.

Application

• Pharmaceutical Intermediate: A key precursor in the multi-step synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders, infectious diseases, or oncology.
• Medicinal Chemistry Research: Serves as a versatile scaffold for constructing compound libraries in high-throughput screening (HTS) campaigns to identify new lead molecules.
• API Development: Used in the process development and scale-up stages for creating active pharmaceutical ingredients (APIs) with complex molecular architectures.
• Chemical Biology Probes: Employed in the design and synthesis of molecular probes for studying biological pathways and target engagement.
• Custom Synthesis & Contract Manufacturing: A critical starting material for CDMOs (Contract Development and Manufacturing Organizations) offering bespoke chemical synthesis services.

Basic Information

Product Name	Allyl 3,9-Diazaspiro[5.5]Undecane-3-Carboxylate Hydrochloride (Wxc00471)
CAS No.	2007909-61-5
Molecular Formula	C13H23ClN2O2
Molecular Weight	274.79 g/mol
Synonyms	Allyl 3,9-diazaspiro[5.5]undecane-3-carboxylate hydrochloride; 3,9-Diazaspiro[5.5]undecane-3-carboxylic acid allyl ester hydrochloride; Allyl 3-aza-9-azaspiro[5.5]undecane-3-carboxylate HCl; WXC-00471; Wxc00471; 2007909-61-5; Allyl ester of 3,9-diazaspiro[5.5]undecane-3-carboxylic acid hydrochloride
EINECS	Contact for details

Quality Control

Every batch of Allyl 3,9-Diazaspiro[5.5]Undecane-3-Carboxylate Hydrochloride is manufactured under a strict quality management system and undergoes comprehensive analytical testing to ensure identity, purity, and consistency. Our products are developed with pharmaceutical applications in mind, adhering to relevant ICH guidelines. A detailed Certificate of Analysis (COA) providing batch-specific results for all critical parameters is supplied with each shipment to support your regulatory and R&D requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). This compound is hygroscopic (moisture-sensitive); therefore, the container must be kept tightly sealed to minimize exposure to atmospheric humidity. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.